PRO-XL: A phase II study of zanzalintinib (XL092) in patients with metastatic castration-resistant prostate cancer (mCRPC) after progression on lutetium-177 (177Lu)-PSMA-617. Mevrometostat ...
The teenage American models who arrived in Paris, far from their parents and hometowns, said the bargain was clear: have sex with their prominent French agent and his wealthy, middle-aged friends or ...
Artificial intelligence, or AI, in the financial sector has moved from the testing lab to the investment desk. Nvidia Corp.'s (ticker: NVDA) 2026 State of AI in Financial Services Report found that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results